Amid rapidly evolving cannabinoid-product and CPG industries, Red Mesa Science & Refining has announced a monumental breakthrough in hemp-derived cannabinoid processing. With the introduction of its botanical refinement method, the company has established a new precedent for naturally derived cannabinoids.
In what marks a significant shift from the industry’s traditional reliance on chemical conversions to produce rare cannabinoids at scale, Red Mesa’s proprietary manufacturing process isolates rare cannabinoids such as CBN, CBT and CBL without chemically catalyzed conversions. Unlike traditional chemical catalyst conversions, Red Mesa’s botanical approach ensures that cannabinoids retain their natural complexity and integrity. This is made possible by extracting and distilling cannabinoids from American-grown hemp and introducing the resulting material to an industrial-scale liquid centrifugal partition chromatography system that precisely isolates the target cannabinoid.
“Achieving a large-scale advancement in production processing methods for botanical minors represents a significant breakthrough for the company and the industry. This innovation opens up new pathways for reliably developing product formulations with these novel minor cannabinoids,” said Brianna Jenkins, Red Mesa’s Director of Chemistry and Quality Assurance. “Currently, conversion reactions are the primary method for supplying most minor cannabinoids, but some state regulators are beginning to restrict their use. Paving the way to create new categories of product outputs is fundamental to our scientific foundation and aligns with our long-term product roadmap goals.”
While pursuing innovation, Red Mesa operates under rigorous oversight, ensuring the utmost quality and accountability. Its dedication to standardized processes is affirmed by its ISO 9001:2015 certification, current Good Manufacturing Practices (cGMP) adherence, FDA registration as a food facility, and compliance with both FDA 21 CFR Part 111 (dietary supplements) and FDA 21 CFR Part 117 (human food). In addition to its botanical refinement method, Red Mesa’s 50,000-square-foot facility incorporates sophisticated, customized equipment across five gates of operation: homogenization, distillation, crystallization, liquid chromatography and conversion.
“As a science-based company that prioritizes quality, Red Mesa continually seeks innovative methods and technological advancements to open new possibilities to lead the industry. We are proud to announce our latest breakthrough in manufacturing technology, botanical refinement,” Red Mesa President Jeff Applegate said. “With this new refining method, we’re balancing the end user’s desires with new opportunities for manufacturers to innovate and broaden the market. Our team’s dedication and ingenuity have brought us to this moment, where we are shaping the future of our company and leading the charge in revolutionizing the way plant-derived products are manufactured.”
This revolutionary botanical refinement process promises a raw material that aligns with consumer preferences for natural ingredients, without compromising on efficacy or safety. The B2B landscape—especially product formulators, white labelers and large-scale brands—stands to benefit significantly from this advancement, gaining access to a uniquely innovative ingredient pathway that fosters full transparency and bolsters product marketability.
H/T: www.cannabisbusinesstimes.com
